Program

Invited Lectures

November 6th (Tuesday)

 

09:00-09:45 

Registration

Chairperson

09:50-10:00

Welcome Address

Hiroshi Terada

Tokyo University of Science

Makoto Haga

(Tokyo University of Science)

10:00-10:40

New Strategies for Control of Chronic Respiratory Infections
  - Focusing on Microbial Biofilms -

Yukihiro Kaneko, Katsunori Yanagihara & Yoshitsugu Miyazaki
National Institute of Infectious Diseases &   Nagasaki University

B. M. Khamar

(Cadila Pharmaceuticals Ltd.)

10:40-11:20

Immunomodulator for Tuberculosis, AIDs and Malaria

Bakulesh M. Khamar
Cadila Pharmaceuticals Ltd

Naoki Yamamoto

(National Institute of Infectious . Diseases)

11:20-12:00

Host-Parasite Relationship: Retroviral Abuse of the Host Proteins/Signaling Pathways and Antiviral Response

Naoki Yamamoto
AIDS Research Center, National Institute  of Infectious Diseases

Yukihiro Kaneko

(National Institute of Infectious Diseases)

12:00-13:30

Lunch

13:30-14:10

Feasibility of the Establishment of Novel Therapies for Tuberculosis and Lung Cancer Focusing on Phagocytotic Activity by Alveolar Macrophage Function

Hiroyuki Inagawa, Chie Kohchi & Gen-ichiro Soma
National Fisheries University & Faculty of  Medicine, Kagawa University

Amarjit Singh
(Panacea Biotec Ltd.)

14:10-14:50

Stable Rifampicin –Isoniazid Fixed Dose Combinations  With Assured and Reproducible Bioavailability

Chamanlal J Shishoo
B. V. Patel PERD Centre

Makoto Haga

14:50-15:30

Discovery of Novel Antituberculosis Drug Candidate  OPC-67683

Masanori Kawasaki & Makoto Matsumoto
Microbiological Research Institute, Otsuka  Pharmaceutical Co., Ltd.

Hiroyuki Inagawa

15:30-16:00

Coffee Break

16:00-16:40

Pulmonary Drug Delivery System for Efficient Treatment of Tuberculosis

Kimiko Makino
Faculty of Pharmaceutical Sciences & Center for Drug Delivery Research, Tokyo University of Science

C.J Shishoo

16:40-17:20

Development of Novel Delivery Systems for Pulmonary DNA Vaccination against Tuberculosis

Gerrit Borchard
Laboratory of Pharmaceutics and Biopharmaceutics, University of Geneva

Tsuneji Nagai 

17:20-17:25

Closing Remark

Tsuneji Nagai
Nagai Foundation Tokyo

Makoto Haga

(Tokyo University of Science)

17:30-19:00

Reception

Chaired by Hiromi Uchiro
(Tokyo University of Science)

 


November 7th (Wednesday)

 

 

Lecture

Chair Person

09:45-10:25

Anti-malarial Drug Development

Yusuke Wataya
Faculty of Pharmaceutical Sciences, Okayama University

K. K. Singh

(SNDT Women's University)

10:25-11:05

Lipid Nanocarriers:

Defying Conventional Antimalarial Therapeutics

Vandana B. Patravale
Institute of Chemical Technology

Yusuke Wataya

(Okayama University)

11:05-11:45

Development of New Antiparasitic Agents Having Novel Mechanism of Action

Masataka Ihara
Institute of Medicinal Chemistry, Hoshi University

V. B. Patravale

(Institute of Chemical Technology)

11:45-12:45

Lunch

 12:45-13:25

Targeted Nanocarrier Systems for Anti-Malarial Chemotherapy

Kamalinder. K. Singh
C.U. Shah College of Pharmacy, SNDT Women's University

Amarjit Singh
(Panacea Biotec Ltd.)

13:25-14:05

 Nano Biotechnology-Current Trends and Future Applications

Amarjit Singh
Panacea Biotec Ltd.

Gerrit Borchard

(University of Geneva)

14:05-15:30

Poster Presentation & Coffee Break    

15:30-16:10

Sendai Virus engineering: From Pure Science to Vaccine Development

Yoshiyuki Nagai
Center
of Research Network for Infectious Diseases, RIKEN

Hans Junginger

(Naresuan University)

16:10-16:50

Micro/nanosized Delivery Systems for Mucosal Vaccination
  - Is Nanosize Always The Best?

Hans Junginger
Department  of Pharmaceutics Faculty of Pharmaceutical SciencesNaresuan University

H. L. Bhalla

(SciTech Centre)

16:50-17:10

Closing Remark

H.L. Bhalla
SciTech Centre

H. Terada

(Tokyo University of Science)



Poster Session

Poster Code

Title

 

P-01


Convenient Synthesis of Zinc Chloride Free 3, 7- Bis­(dialkylamino)phenoxazinium for Medicinal Purpose

Jian-Feng Ge,  Chika Arai,  Masataka Ihara
Institute of Medicinal Chemistry, Hoshi University

 

P-02


Antimalaria in vitro and in vivo Activities of Phenoxa­zinium Salts

Chika Arai, Jian-Feng Ge,  Masataka Ihara
Institute of Medicinal Chemistry, Hoshi University

 

P-03


Synthetic Study of Novel Decahydrofluorene-type Natural Products to Develop a New Class of Antibiotics against Multidrug-resistant Strains

Hiromi Uchiro, Daiju Hasegawa, Yoshikazu Sakuma, Yohei Takagi & Yuki Karoji
Faculty of Pharmaceutical Sciences, & Center for Drug Delivery Research, Tokyo University of Science

 

P-04


Self-microemulsifying Suppositories of β-artemether for Anti Malarial Therapeutics

Dalapathi G., Umangi Soni , Vandana Patravale &
 Shobhona Sharma
Institute Of Chemical Technology (autonomous) &

Tata Institute of Fundamental Research

 

P-05


Lipid Nanoparticles of Nevirapine for Targeting Latent HIV Reservoirs

Ranjita Shegokar & Kamalinder K. Singh
C.U.Shah College of Pharmacy, S.N.D.T. Women’s University


 

P-06


Pulmonary Administration System of Ciprofloxacin Incorporated into Liposomes for Treatment of Respiratory Intracellular Parasite Infections

Kazuhiro Morimoto, Kouhei Togami, Keita Kaneko,
Sumio Chono & Toshinobu Seki
Hokkaido Pharmaceutical University


 

P-07


Efficacy of Pulmonary Administration of Telithromycin for The Treatment of Respiratory Infections

Kouhei Togami, Sumio Chono, Yuko Saso, Toshinobu Seki & Kazuhiro Morimoto
Hokkaido Pharmaceutical University

 

P-08

Comparative Efficacy of Long Acting Amoxycillin Injection in an Experimental Model Murine for Respi­ratory Tract Infection

Sumedha Nadkar & Kamalinder K. Singh
C.U. Shah College of Pharmacy, S.N.D.T Women’s University

 

P-09


Pentazocine Transdermal Drug Delivery System:
A Comparative Pharmacokinetic Evaluation

Ashok R. Chandak & P. R. P. Verma
Department of Pharmaceutical Sciences,

Birla Institute of Technology

 

P-10


Pharmacokinetic Characterization of Matrix Dispersion Type Transdermal Drug Delivery System of Tramadol

Ashok R. Chandak & P. R. P. Verma
Department of Pharmaceutical Sciences,

Birla Institute of Technology

 

P-11


Study of Solid-Solid Interaction of Rifampicin and Isoniazid by Differential Scanning Calorimetry

Swati Pund, Amita Joshi, Kamala Vasu,
Manish Nivsarkar & Chamanlal Shishoo
B. V. Patel PERD Centre


 

P-12


Design and Development of a Novel Site-Specific Delivery System of Rifampicin and Isoniazid for Improved Stability and Bioavailability

Amita Joshi, Swati Pund, Manish Nivsarkar,
Kamala Vasu & Chamanlal Shishoo
B. V. Patel PERD Centre

 

P-13


Development of Monoclonal Antibody to Lipid Rafts of Macrophage

Kazuo Ishii1, Goushi Nagao, Takao Taki, & Hiroshi Terada
Center for Drug Delivery Research, and Faculty of Pharmaceutical Sciences, Tokyo University of Science, Otsuka Pharmaceutical Co. Ltd.

 

P-14


LIPOMERS: OPTIMIZATION OF LIPID CONCENTRATION FOR SPLENIC TARGETING

R. R. Patil, R.V. Gaikwad, A. Samad & P. V. Devarajan
Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, University of Mumbai &  Veterinary Nuclear Medicine Center, Bombay Veterinary College

 

P-15


A PROADHESIVE PEPTIDE DERIVED FROM TENASCIN-C (TNIIIA2) INHIBITS MYCOBACTERIUM TUBERCULOSIS SURVIVAL IN INFECTED MACROPHAGES BY INDUCING AUTOPHAGY

Toshiyuki Owaki, Tomokazu Shimada, Kiyomi Mochizuki, Yoshihiro Senga, Shunsuke Kumokoshi, Fumio FukaiFaculty of Pharmaceutical Sciences,
Tokyo University of Science